Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function
- PMID: 66973
- DOI: 10.1002/1097-0142(197704)39:4<1430::aid-cncr2820390412>3.0.co;2-v
Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function
Abstract
Serum and plasma bleomycin concentrations were determined in a patient with renal dysfunction at two creatinine clearances. The results obtained with a new radioimmunoassay and the microbiologic assay were compared. It was shown: 1) that the clearance of bleomycin from the blood is markedly retarded in severe renal dysfunction, 2) that clearance of bleomycin varies with creatinine clearance, 3) that bleomycin is probably not dialyzable, 4) that determinations on serum and plasma were equivalent, and 5) that the radioimmunoassay and microbiologic assays gave equivalent results (P less than 0.001).
Similar articles
-
Bleomycin clinical pharmacology by radioimmunoassay.Cancer Chemother Pharmacol. 1982;9(1):22-5. doi: 10.1007/BF00296756. Cancer Chemother Pharmacol. 1982. PMID: 6183016
-
Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.Cancer Treat Rep. 1977 Dec;61(9):1631-6. Cancer Treat Rep. 1977. PMID: 74282
-
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay.Cancer. 1977 Dec;40(6):2772-8. doi: 10.1002/1097-0142(197712)40:6<2772::aid-cncr2820400603>3.0.co;2-1. Cancer. 1977. PMID: 73408
-
Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis.Trans Am Soc Artif Intern Organs. 1981;27:45-50. Trans Am Soc Artif Intern Organs. 1981. PMID: 7331111
-
Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.Clin Toxicol (Phila). 2011 Oct;49(8):720-8. doi: 10.3109/15563650.2011.615319. Clin Toxicol (Phila). 2011. PMID: 21970770 Review.
Cited by
-
Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report.J Med Case Rep. 2017 Feb 16;11(1):43. doi: 10.1186/s13256-017-1213-7. J Med Case Rep. 2017. PMID: 28202048 Free PMC article.
-
Clinical relevance of pharmacokinetics.Clin Pharmacokinet. 1980 Mar-Apr;5(2):105-36. doi: 10.2165/00003088-198005020-00001. Clin Pharmacokinet. 1980. PMID: 6102499 Review. No abstract available.
-
Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer--dosimetric and biokinetic aspects.Eur J Nucl Med. 1996 Jun;23(6):631-8. doi: 10.1007/BF00834524. Eur J Nucl Med. 1996. PMID: 8662096
-
Bleomycin clinical pharmacology by radioimmunoassay.Cancer Chemother Pharmacol. 1982;9(1):22-5. doi: 10.1007/BF00296756. Cancer Chemother Pharmacol. 1982. PMID: 6183016
-
Bleomycin pharmacokinetics in man. I. Intravenous administration.Cancer Chemother Pharmacol. 1978;1(3):177-81. doi: 10.1007/BF00253118. Cancer Chemother Pharmacol. 1978. PMID: 86392 No abstract available.